• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Hypopharynx Cancer - Pipeline Review, Q4 2010 - Product Image

Hypopharynx Cancer - Pipeline Review, Q4 2010

  • ID: 1474084
  • December 2010
  • 27 pages
  • Global Markets Direct

Hypopharynx Cancer - Pipeline Review, Q4 2010

Summary

Global Markets Direct’s, “Hypopharynx Cancer Pipeline Review, Q4 2010”, provides an overview of the Hypopharynx Cancer therapeutic pipeline. This report provides information on the therapeutic development for Hypopharynx Cancer , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypopharynx Cancer . “Hypopharynx Cancer -Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- A snapshot of the global therapeutic scenario for Hypopharynx Cancer   .
- A review of the Hypopharynx Cancer    products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage READ MORE >



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hypopharynx Cancer Overview
An Overview of Pipeline Products for Hypopharynx Cancer
Hypopharynx Cancer Therapeutics under Development by Companies
Hypopharynx Cancer Therapeutics under Investigation by Universities/Institutes
Companies Involved in Hypopharynx Cancer Therapeutics Development
Universities/Institutes Involved in Hypopharynx Cancer Therapeutics Development
Hypopharynx Cancer Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles – Universities/Institutes
Cisplatin + Fluorouracil + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Panitumumab + Cisplatin + Fluorouracil + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Radiation Therapy + Cetuximab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos